Zevra Drug Patent Portfolio
Zevra owns 2 orange book drugs protected by 8 US patents Given below is the list of Zevra's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8461137 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 22 Feb, 2031 | Active |
| US8748413 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 01 Jul, 2030 | Active |
| US8828978 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 01 Jul, 2030 | Active |
| US9132125 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | 01 Jul, 2030 | Active |
| US9549923 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof | 01 Jul, 2030 | Active |
| US11045460 | Use of Hsp70 as a regulator of enzymatic activity | 19 Aug, 2029 | Active |
| US9289472 | Use of HSP70 as a regulator of enzymatic activity | 11 Aug, 2029 | Active |
| US9884058 | Use of Hsp70 as a regulator of enzymatic activity | 26 Jun, 2029 | Active |
Latest Legal Activities on Zevra's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Zevra.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 23 Feb, 2023 | US9132125 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 02 Mar, 2022 | US8828978 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 06 Oct, 2021 | US8748413 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 12 Oct, 2020 | US8461137 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 21 May, 2020 | US9549923 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 22 Feb, 2019 | US9132125 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 22 Feb, 2018 | US8828978 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 Nov, 2017 | US8748413 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Jan, 2017 | US9549923 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Jan, 2017 | US9549923 |
|
Email Notification
Critical
| 05 Jan, 2017 | US9549923 |
|
Issue Notification Mailed
Critical
| 04 Jan, 2017 | US9549923 |
| Dispatch to FDC | 19 Dec, 2016 | US9549923 |
|
Application Is Considered Ready for Issue
Critical
| 17 Dec, 2016 | US9549923 |
|
Issue Fee Payment Verified
Critical
| 12 Dec, 2016 | US9549923 |
Zevra's Family Patents
Zevra Drug List
Given below is the complete list of Zevra's drugs and the patents protecting them.
1. Apadaz
Apadaz is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8461137 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
22 Feb, 2031
(5 years from now)
| Active |
| US8748413 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
01 Jul, 2030
(4 years from now)
| Active |
| US8828978 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
01 Jul, 2030
(4 years from now)
| Active |
| US9132125 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
01 Jul, 2030
(4 years from now)
| Active |
| US9549923 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof |
01 Jul, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Apadaz's drug page
2. Miplyffa
Miplyffa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11045460 | Use of Hsp70 as a regulator of enzymatic activity |
19 Aug, 2029
(3 years from now)
| Active |
| US9289472 | Use of HSP70 as a regulator of enzymatic activity |
11 Aug, 2029
(3 years from now)
| Active |
| US9884058 | Use of Hsp70 as a regulator of enzymatic activity |
26 Jun, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miplyffa's drug page